BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32318859)

  • 1. Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients.
    Godi I; De Rosa S; Martino F; Bazzano S; Martin M; Boni E; Carta MR; Tamayo Diaz C; Mari G; Lorenzin A; de Cal M; Corradi V; Caprara C; Giavarina D; Ronco C
    Ann Intensive Care; 2020 Apr; 10(1):46. PubMed ID: 32318859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
    Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
    PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study.
    Licheng ; Jia H; Jiang Y; Li W
    BMC Nephrol; 2024 May; 25(1):153. PubMed ID: 38702662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging.
    Molinari L; Del Rio-Pertuz G; Smith A; Landsittel DP; Singbartl K; Palevsky PM; Chawla LS; Huang DT; Yealy DM; Angus DC; Kellum JA;
    JAMA Netw Open; 2022 May; 5(5):e2212709. PubMed ID: 35583867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-cycle arrest biomarkers in urine to predict acute kidney injury in septic and non-septic critically ill patients.
    Cuartero M; Ballús J; Sabater J; Pérez X; Nin N; Ordonez-Llanos J; Betbesé AJ
    Ann Intensive Care; 2017 Sep; 7(1):92. PubMed ID: 28884304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A promising marker in early diagnosis of septic acute kidney injury of critically ill patients: urine insulin like growth factor binding protein-7.
    Aydoğdu M; Boyacı N; Yüksel S; Gürsel G; Sivri AB
    Scand J Clin Lab Invest; 2016 Sep; 76(5):402-10. PubMed ID: 27240440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of urinary C-C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study.
    Qian BS; Jia HM; Weng YB; Li XC; Chen CD; Guo FX; Han YZ; Huang LF; Zheng Y; Li WX
    J Intensive Care; 2023 Mar; 11(1):11. PubMed ID: 36941674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle arrest biomarkers for predicting renal recovery from acute kidney injury: a prospective validation study.
    Jia HM; Cheng L; Weng YB; Wang JY; Zheng X; Jiang YJ; Xin X; Guo SY; Chen CD; Guo FX; Han YZ; Zhang TE; Li WX
    Ann Intensive Care; 2022 Feb; 12(1):14. PubMed ID: 35150348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum procalcitonin levels predict acute kidney injury in critically ill patients.
    Jeeha R; Skinner DL; De Vasconcellos K; Magula NP
    Nephrology (Carlton); 2018 Dec; 23(12):1090-1095. PubMed ID: 28967168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure.
    Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M
    Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of biomarker with clinical risk factors for prediction of severe acute kidney injury in critically ill patients.
    Jia L; Sheng X; Zamperetti A; Xie Y; Corradi V; Chandel S; De Cal M; Montin DP; Caprara C; Ronco C
    BMC Nephrol; 2020 Dec; 21(1):540. PubMed ID: 33302892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery.
    Wang Y; Zou Z; Jin J; Teng J; Xu J; Shen B; Jiang W; Zhuang Y; Liu L; Luo Z; Wang C; Ding X
    BMC Nephrol; 2017 May; 18(1):177. PubMed ID: 28558754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study.
    Ferrari F; Romero-González G; Topete LR; Senzolo M; Lorenzin A; Husain-Syed F; Puci MV; Ferraro OE; Muraro E; Serrano-Soto M; Triviño AM; Castro AC; Xie Y; Yang B; De Cal M; Corradi V; Brendolan A; Scarpa M; Carta MR; Giavarina D; Bonato R; Ronco C
    Sci Rep; 2019 Nov; 9(1):16484. PubMed ID: 31712687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
    Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
    Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors.
    Adler C; Heller T; Schregel F; Hagmann H; Hellmich M; Adler J; Reuter H
    Crit Care; 2018 May; 22(1):126. PubMed ID: 29751827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsis.
    Tao X; Chen C; Luo W; Zhou J; Tian J; Yang X; Hou FF
    BMC Nephrol; 2021 Dec; 22(1):415. PubMed ID: 34906098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.